Gennex Laboratories Share Price

ABOUT Gennex Laboratories

• Industry Biotechnology & Drugs
• ISIN INE509C01026
• BSE Code 531739

Gennex Laboratories Limited is an India-based active pharmaceutical ingredient manufacturing company. The Company is engaged in the business of manufacturing bulk drugs, intermediaries, and biotech products. The Company has a robust product portfolio spread over product segments encompassing Expectorants, Muscle Relaxants, Analgesic and Anti-Fungal. The Company operates through the Pharmaceutical Products (Bulk Drugs) segment. The Company's products include active pharmaceutical ingredients, such as Guaifenesin USP/BP/EP/IP, which is an expectorant, (mucolyte); Methocarbamol USP/IP, which is a relaxant (skeletal muscle relaxant); Phenazopyridine Hcl USP, which is an urinary tract analgesic; Fluconazole EP/BP/USP/IP, which is an anti-fungal product; Mephenesin IP/BP, which is a muscle relaxant; Sertraline Hcl, which is a selective serotonin reuptake inhibitors (SSRIS), and others. The Company has manufacturing facilities in India which cater to both domestic and international markets.

MANAGEMENT

• K. Bhaswanth Chief Operating Officer, Compliance Officer
• Arihant Baid Managing Director, Director
• Tiruvarur Gopalakrishnan Whole Time Director